Leah Rosenbaum was an editorial intern at Science News in the summer of 2018. She has two bachelor’s degrees from Johns Hopkins University in writing and public health. She is currently a graduate student at UC Berkeley, completing a combined Masters of Journalism and Masters of Public Health program, with a focus on infectious diseases and vaccines. Her freelance work has appeared in STAT News, Tonic (Vice), and Health News Review, among other publications.

Trustworthy journalism comes at a price.
Scientists and journalists share a core belief in questioning, observing and verifying to reach the truth. Science News reports on crucial research and discovery across science disciplines. We need your financial support to make it happen – every contribution makes a difference.
All Stories by Leah Rosenbaum
- Health & Medicine
What we know — and don’t know — about a new migraine drug
A migraine prevention drug was recently approved by the U.S. Food and Drug Administration. But some questions about the therapy remain.